← feed

Is NCT01389206 results overdue?

Yes — results are overdue. Primary completion was 2018-04-10; the FDAAA-801 reporting deadline (2019-04-10) passed 2675 days ago and no results are posted on ClinicalTrials.gov.

Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program

NCT IDNCT01389206 ↗
SponsorActelion (INDUSTRY)
Phase
StatusCOMPLETED
Primary completion2018-04-10 (ACTUAL)
Reporting deadline2019-04-10 (completion + 365d)
Days overdue2675
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 2b59891c5df9b1dd… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT01389206. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →